See for example Weiss, R., “Stem Cell Bill Easily Clears Senate but Lacks Votes to Override a Veto,” Washington Post, April 12, 2007; Smith, S., Neaves, W., and Teitelbaum, S., “Adult Stem Cell Treatments for Diseases?” Science 313, no. 5786 (2006): 439; Enserink, M., “Selling the Stem Cell Dream,” Science 313, no. 5784 (2006): 160–163; Applebaum, A., “Stem Cell Stumping,” Washington Post, August 4, 2004.Google Scholar

Couzin, J., “Celebration and Concern over U.S. Trial of Embryonic Stem Cells,” Science 323, no. 5914 (2009): 568.CrossRefGoogle Scholar

Vogel, G, “Ready or Not? Human ES Cells Head Toward the Clinic,” Science 308, no. 5728 (2005): 1534–1538.Google Scholar

See Normile, D., Vogel, G., and Couzin, J., “South Korean Team's Remaining Human Stem Cell Claims Demolished,” Science 311, no. 5758 (2006): 156–157.CrossRefGoogle Scholar

Solter, D., “Politically Correct Human Embryonic Stem Cells?” New England Journal of Medicine 354, no. 11 (2006): 1209.Google Scholar

National Institutes of Health, “Stem Cell Basics,” April 28, 2009, available at <http://stemcells.nih.gov/info/basics/defaultpage> (last visited March 11, 2010).+(last+visited+March+11,+2010).>Google Scholar

See National Institutes of Health, supra note 6, at 17. See also Demick, B., “Hopes Founder on ‘Big Lie,’” Los Angeles Times, January 9, 2006.Google Scholar

Martin, T. J., “Reactions to the Hwang Scandal,” Science 311, no. 5761 (2006): 607; Couzin, J., “… And How the Problems Eluded Peer Reviewers,” Science 311, no. 5757 (2006): 23–24.Google Scholar

Holden, C., “Battle Heats Up Over Cloning,” Science 295, no. 5552 (2002): 2009.Google Scholar

Gramling, C., “Random Samples: People,” Science 309, no. 5742 (2005): 1937; Paarlberg, R. L., “The Great Stem Cell Race,” Foreign Policy (May-June 2005): 44–51.Google Scholar

See Holden, C., “States, Foundations Lead the Way After Bush Vetoes Stem Cell Bill,” Science 313, no. 5786 (2006): 420–421; Paarlberg, R., “The Great Stem Cell Race,” at 49–51.CrossRefGoogle Scholar

Okie, S., “Stem-Cell Politics,” New England Journal of Medicine 355, no. 16 (2006): 1633–1637.CrossRefGoogle Scholar

“Kerry's Acceptance: ‘We Have It in Our Power to Change the World Again,’” New York Times, July 30, 2004; “Ron Reagan's Speech to the Democratic National Convention,” New York Times, July 27, 2004; Editorial, “Better to be Talked About …,” Nature 431, no. 7006 (2004): 229.CrossRefGoogle Scholar

Editorial, “Stem Cell Politics,” Washington Post, January 13, 2006; Connolly, C., “Waging the Battle for Stem Cell Research,” Washington Post, June 9, 2002.Google Scholar

See “Stem Cell Research Advocates Concerned McCain Will Backtrack on Support If Elected President,” September 23, 2008, available at <http://www.medicalnewstoday.com/printerfriendlynews.php?newsid=122493> (last visited March 11, 2010).+(last+visited+March+11,+2010).>Google Scholar

See Holden, C., “Scientists Look to Missouri to Show the Way for Stem Cells,” Science 314, no. 5800 (2006): 737–738; Franck, M., “Stem Cell Fight Shatters Spending Records,” St. Louis Post-Dispatch (October 17, 2006); Mannies, J., “Talent, McCaskill Put Contrasts on Display During Debate,” St. Louis Post-Dispatch (October 11, 2006); Citizens for Barbara Fraser for County Council, “Fresh Idea #1: St. Louis County Will Benefit from Stem Cell Research,” Campaign Brochure (2006).Google Scholar

Sulmasy, D. P., “Deliberative Democracy and Stem Cell Research in New York State: The Good, the Bad, and the Ugly,” Kennedy Institute of Ethics Journal 19, no. 1 (2009): 63–78.CrossRefGoogle Scholar

See Malakoff, D., “The Calculus of Making Stem Cells a Campaign Issue,” Science 305, no. 5685 (2004): 760.CrossRefGoogle Scholar

See, e.g., Kiatpongsan, S. and Sipp, D., “Monitoring and Regulating Offshore Stem Cell Clinics,” Science 323, no. 5921 (2009): 1564–1565; Shaywitz, D., “Stem Cell Hype and Hope,” Washington Post, January 12, 2006.CrossRefGoogle Scholar

Wilson, J. M., “A History Lesson for Stem Cells,” Science 324, no. 5928 (2009): 727–728.CrossRefGoogle Scholar

Id.Google Scholar

See, e.g., Wade, N., “Rethink Stem Cells? Science Already Has,” New York Times, March 10, 2009.Google Scholar

See Wilson, , supra note 20, at 728 (describing media coverage of the clinical trial).Google Scholar

Harris, G., “Pick to Lead Health Agency Draws Praise and Some Concern,” New York Times, July 9, 2009.Google Scholar

Wade, N., “Some Scientists See Shift in Stem Cell Hopes,” New York Times, August 14, 2006; Weiss, R., “Harvard Announces Private Project to Make Human Stem Cells,” Washington Post, June 7, 2006.Google Scholar

Working Group on Setting Research Priorities, Setting Research Priorities at the National Institutes of Health, NIH Publication No. 97–4265 (1997): at 8–9. Stem cell research, like a substantial percentage of the studies NIH funds, comes under the heading of basic science. Basic science studies investigate problems in biology potentially relevant to many health conditions. But in response to pressure from Congress and advocacy organizations concerned about funding allocation, NIH requires researchers submitting basic science study proposals to describe the specific health applications of their work. Officials use this information to produce annual estimates of the support it gives to research on different medical conditions. These estimates have limited utility, however, because they combine general research categories, such as stem cell research, with specific disease categories, such as Alzheimer's disease. In addition, funded projects may be listed in more than one category. Critics say that the loose categorization system functions to give NIH officials substantial discretion over where the money actually goes. For estimates covering fiscal years 2005–2010, see “Estimates of Funding for Various Research, Condition, and Disease Categories,” January 15, 2009, available at <http://report.nih.gov/rcdc/categories/PFSummaryTable.aspx> (last visited March 12, 2010). (last visited March 12, 2010).' href=https://scholar.google.com/scholar?q=Working+Group+on+Setting+Research+Priorities,+Setting+Research+Priorities+at+the+National+Institutes+of+Health,+NIH+Publication+No.+97–4265+(1997):+at+8–9.+Stem+cell+research,+like+a+substantial+percentage+of+the+studies+NIH+funds,+comes+under+the+heading+of+basic+science.+Basic+science+studies+investigate+problems+in+biology+potentially+relevant+to+many+health+conditions.+But+in+response+to+pressure+from+Congress+and+advocacy+organizations+concerned+about+funding+allocation,+NIH+requires+researchers+submitting+basic+science+study+proposals+to+describe+the+specific+health+applications+of+their+work.+Officials+use+this+information+to+produce+annual+estimates+of+the+support+it+gives+to+research+on+different+medical+conditions.+These+estimates+have+limited+utility,+however,+because+they+combine+general+research+categories,+such+as+stem+cell+research,+with+specific+disease+categories,+such+as+Alzheimer's+disease.+In+addition,+funded+projects+may+be+listed+in+more+than+one+category.+Critics+say+that+the+loose+categorization+system+functions+to+give+NIH+officials+substantial+discretion+over+where+the+money+actually+goes.+For+estimates+covering+fiscal+years+2005–2010,+see+“Estimates+of+Funding+for+Various+Research,+Condition,+and+Disease+Categories,”+January+15,+2009,+available+at++(last+visited+March+12,+2010).>Google Scholar

See Dresser, R., “Private-Sector Research Ethics: Marketing or Good Conflicts Management?” Theoretical Medicine and Bioethics 27, no. 2 (2006): 115–39.CrossRefGoogle Scholar

See Hegde, D. and Mowery, D., “Politics and Funding in the U.S. Public Biomedical R&D System,” Science 322, no. 5909 (2008): 1797–1798. I address these issues in depth in Dresser, R., When Science Offers Salvation: Patient Advocacy and Research Ethics (Oxford University Press, 2001). See also Callahan, D., What Price Better Health? Hazards of the Research Imperative (University of California Press, 2003). For an analysis and critique of NIH priority setting, see Institute of Medicine, Scientific Opportunities and Public Needs: Improving Priority Setting and Public Input at the National Institutes of Health (Washington, D.C.: National Academy Press, 1998).Google Scholar

See generally Gostin, L., “Why Rich Countries Should Care about the World's Least Healthy People,” JAMA 298, no. 1 (2007): 89–91.CrossRefGoogle Scholar

Hall, S., Merchants of Immortality: Chasing the Dream of Human Life Extension (New York: Houghton Mifflin, 2003); Wade, N., “Apostle of Regenerative Medicine Foresees Longer Health and Life,” New York Times, December 18, 2001.Google Scholar

See Callahan, , supra note 28, at 32, 73–84, 232, 266, 275.Google Scholar

Faden, R. et al., “Public Stem Cell Banks: Considerations of Justice in Stem Cell Research and Therapy,” Hastings Center Report 33, no. 6 (2003): 13–27, note 2.CrossRefGoogle Scholar

See Shannon, T., “From the Micro to the Macro,” in The Human Embryonic Stem Cell Debate, edited by Holland, S., Lebacqz, K., and Zoloth, L. (Cambridge: MIT Press, 2001): 177–84.Google Scholar

See Huang, F. and Stremlau, M., “Disease Researchers Neglecting World Poor,” Los Angeles Times, April 30, 2002.Google Scholar

Utzinger, J. and de Savigny, D., “Control of Neglected Tropical Diseases: Integrated Chemotherapy and Beyond,” PLoS Medicine 3, no. 5 (May 2006): e112.CrossRefGoogle Scholar

See Callahan, , supra note 28, at 262.Google Scholar

See “AAAS President Calls to Restore American Health System,” February 13, 2003, available at <http://eurekalert.org/pub_releases/2003-02/aaft-apc020303.php> (last visited March 12, 2010).+(last+visited+March+12,+2010).>Google Scholar

Callahan, D., “The ‘Research Imperative’: Is Research a Moral Obligation?” President's Council on Bioethics Meeting, July 24, 2003, available at <http://bioethicsprint.bioethics.gov/tran-scripts/july03/session1.html> (last visited March 12, 2010).Google Scholar

See generally DeGrazia, D., “Single Payer Meets Managed Competition,” Hastings Center Report 38, no. 1 (2008): 23–33.CrossRefGoogle Scholar

See generally Grady, D., “Where Life's Start Is a Deadly Risk,” New York Times, May 24, 2009; Cohen, J., “The New World of Global Health,” Science 311, no. 5758 (2006): 162–67.Google Scholar

See Callahan, , supra note 28, at 268–276. For a general critique of the U.S. approach to biomedical research funding, see Dresser, R., “Priority Setting in Biomedical Research,” AMA Journal of Ethics 11, no. 4 (2009): 322–325, available at <http://www.virtualmentor.org> (last visited March 12, 2010).Google Scholar

Goldstein, A., “A President Presses Senate to Ban All Human Cloning,” Washington Post, April 11, 2002.Google Scholar

See Strode, T., “Pro-Lifers Criticize Report by President's Bioethics Council,” BPNews, April 4, 2004, available at <http://bpnews.net/BPnews.asp?ID=17986> (last visited March 12, 2010).Google Scholar

See “Better To Be Talked About…,” supra note 13, at 229.Google Scholar

Alter, J., “The ‘Pro-Cure’ Movement,” Newsweek, June 6, 2005, at 27.Google Scholar

Vogelstein, B., Alberts, B., and Shine, K., “Please Don't Call It Cloning!” Science 295, no. 5558 (2002): 1237.CrossRefGoogle Scholar

President's Council on Bioethics, Human Cloning and Human Dignity: An Ethical Inquiry, 2002, at 41–63, available at <http://bioethics.georgetown.edu.pcbe/reports.cloningre-port/> (last visited March 24, 2010). (last visited March 24, 2010).' href=https://scholar.google.com/scholar?q=President's+Council+on+Bioethics,+Human+Cloning+and+Human+Dignity:+An+Ethical+Inquiry,+2002,+at+41–63,+available+at++(last+visited+March+24,+2010).>Google Scholar

See, e.g., “DeGette and Castle Respond to NIH Guidelines,” July, 6, 2009, available at <http://degette.house.gov/index.php?option=com_content&view=article&id=787:degette-and-castle-respond-to-nih-guidelines&catid=89:health> (last visited March 12, 2010).+(last+visited+March+12,+2010).>Google Scholar

Thompson, D. and Gutmann, A., Why Deliberative Democracy? (Princeton University Press, 2004): at 3–4.Google Scholar

Id., at 4.Google Scholar

Id., at 5–7.Google Scholar

Id., at 86–90.Google Scholar

Id., at 86.Google Scholar

Id., at 7.Google Scholar

Scientists are getting closer to developing alternative sources of stem cells that could dispense with the need to destroy embryos to obtain such cells. See Vogel, G., “Reprogramming Cells,” Science 322, no. 5884 (2008): 1766–1767. If this happens, it is possible that officials will decide to limit government support to research on stem cell lines created using methods that avoid embryo destruction.CrossRefGoogle Scholar

“Obama's Remarks on Stem Cell Research,” March 9, 2009, available at <http://www.nytimes.com/2009/03/09/us/politics/09text-obama.html> (last visited July 13, 2009). For commentary on the lack of robust moral argument in the remarks, see Steinfels, P., “In Stem Cell Debate, Moral Suasion Comes Up Short,” New York Times, March 14, 2009.Google Scholar

See “Obama's Remarks on Stem Cell Research,” supra note 56.Google Scholar

National Institutes of Health Guidelines on Human Stem Cell Research, available at <http://stemcells.nih.gov/policy/2009guidelines.htm> (last visited March 12, 2010).+(last+visited+March+12,+2010).>Google Scholar

Id., at 3.Google Scholar

Kington, R., Stem Cell Press Briefing, July 6, 2009. See also Trapp, D., “NIH Lifts Main Stem Cell Funding Restrictions,” American Medical News, July 27, 2009.Google Scholar

For an analysis applying deliberative democracy principles to New York's approach to human embryonic stem cell research, see Sulmasy, , supra note 17.Google Scholar

See Steinfels, , supra note 56 (quoting one congressional representative who “equated opposition to embryonic stem cell research with refusing ‘a cure for your child's cancer’” and another who said such opposition was equivalent to “a sentence of death of millions of Americans”).Google Scholar

Annas, G., Caplan, A., and Elias, S., “Stem Cell Politics, Ethics, and Moral Progress,” Nature Medicine 5, no. 12 (1999): 1339–1341.CrossRefGoogle Scholar

Schechter, A. and Rettig, R., “Funding Priorities for Medical Research,” JAMA 288, no. 7 (2002): 832.CrossRefGoogle Scholar

Kass, L., “Foreword,” in President's Council on Bioethics, Human Cloning and Human Dignity, at XIII-XXIII.Google Scholar